SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,618.00    32.00 (0.70%)
Bid:
4,618.00
Ask:
4,620.00
Spread: 2.00 (0.043%)
Market Cap: £16.83b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Issue of Debt

15 Sep 2022 08:49

RNS Number : 5860Z
Coca-Cola HBC AG
15 September 2022
 

Coca-Cola HBC Finance B.V.

 (a private limited liability company incorporated in the Netherlands)

Guaranteed by:

Coca-Cola HBC AG

 (a company incorporated with limited liability in Switzerland)

 

Launch of Issue of Notes

Zug, Switzerland and Amsterdam, The Netherlands - 15 September 2022 - Coca-Cola HBC AG ("Coca-Cola HBC") and Coca-Cola HBC Finance B.V. (the "Issuer") today announce the launch of a Euro denominated 3-year fixed-rate issue of Notes (the "Notes"), to be issued by the Issuer under its €5 billion Euro Medium Term Note Programme, subject to market conditions.

The Notes will be guaranteed by Coca-Cola HBC.

This announcement must be read in conjunction with the Base Prospectus dated 6 September 2022 (the "Base Prospectus") which constitutes a base prospectus for the purposes of Regulation (EU) 2017/1129 as it forms part of domestic law in the United Kingdom by virtue of the European Union (Withdrawal) Act 2018.

Application will be made for the Notes to be admitted to the Official List of the Financial Conduct Authority and to trading on the Regulated Market of the London Stock Exchange plc.

Coca-Cola HBC intends that an amount equal to the net proceeds of the Notes will be used for Eligible Green Projects in accordance with the requirements set out in Coca-Cola HBC's Green Finance Framework, available on Coca-Cola HBC's website at: https://www.coca-colahellenic.com/en/investor-relations/debt-investors.

Disclaimer

Neither this announcement nor the Base Prospectus constitute an offer of securities for sale in the United States. The Notes have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold within the United States or to or for the account or benefit of U.S. persons except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Accordingly, the Notes will be offered only in offshore transactions to non-U.S. persons in reliance upon Regulation S under the Securities Act.

 

Please note that the information contained in this announcement and/or the Base Prospectus referred to above may be addressed to and/or targeted at persons who are residents of particular countries (specified in this announcement and/or the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in this announcement and/or the Base Prospectus is not addressed. Prior to relying on the information contained in this announcement and/or the Base Prospectus you must ascertain from this announcement and the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

 

Your right to access this service is conditional upon complying with the above requirements.

 

Enquiries

Coca‑Cola HBC Group

Investors and Analysts:

Joanna Kennedy

Head of Investor Relations

 

Tel: +44 7802 427505

 joanna.kennedy@cchellenic.com

Jemima Benstead

Investor Relations Manager

 

Tel: +44 7740 535130

jemima.benstead@cchellenic.com

Marios Matar

Investor Relations Manager

 

Tel: +30 697 444 3335

marios.matar@cchellenic.com

Media:

Sonia Bastian

Head of Communications

 

 

Tel: +41 7946 88054

sonia.bastian@cchellenic.com

 

ABOUT COCA-COLA HBC

Coca-Cola HBC is a growth-focused consumer packaged goods business and strategic bottling partner of The Coca-Cola Company. We create value for all our stakeholders by supporting the socio-economic development of the communities in which we operate and we believe building a more positive environmental impact is integral to our future growth. Together, we and our customers serve 715 million consumers across a broad geographic footprint of 29 countries on three continents. Our portfolio is one of the strongest, broadest and most flexible in the beverage industry, offering consumer-leading beverage brands in the sparkling, juice, water, sport, energy, plant-based, ready-to-drink tea, coffee, adult sparkling and premium spirits categories. These beverages include Coca-Cola, Coca-Cola Zero, Schweppes, Kinley, Costa, Valser, Romerquelle, Fanta, Sprite, Powerade, FuzeTea, Dobry, Cappy, Monster and Adez. We foster an open and inclusive work environment amongst our 33,000 employees and we are ranked among the top sustainability performers in ESG benchmarks such as the Dow Jones Sustainability Indices, CDP, MSCI ESG and FTSE4Good.

 

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE:CCH) and is listed on the Athens Exchange (ATHEX:EEE). For more information, please visit https://www.coca-colahellenic.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IODEAXNSFLKAEEA
Date   Source Headline
22nd May 20263:30 pmRNSDirector/PDMR Shareholding
19th May 20263:15 pmRNSDirector/PDMR Shareholding
11th May 20269:00 amRNSDirector Declaration
8th May 20263:15 pmRNSComposition of the Board Committees
8th May 20263:10 pmRNSResult of AGM
7th May 20267:00 amRNSStrong volume drives Q1 sales growth
20th Apr 20263:15 pmRNSDirector/PDMR Shareholding
14th Apr 202612:15 pmRNSNotice of Results
2nd Apr 20267:00 amRNSNotice of AGM, changes to the BoD, dividend dates
1st Apr 20269:15 amRNSTransfer of treasury shares & total voting rights
31st Mar 202611:00 amRNSPublication of Final Terms
27th Mar 20262:45 pmRNSDirector/PDMR Shareholding
27th Mar 20262:15 pmRNSDirector/PDMR Shareholding
26th Mar 20266:18 pmRNSPricing of Issue of Notes
26th Mar 20269:05 amRNSLaunch of Issue of Notes
25th Mar 20261:36 pmRNSPublication of a Prospectus
20th Mar 202611:00 amRNSAnnual Financial Report
19th Mar 20264:55 pmRNSDirector/PDMR Shareholding
19th Mar 20264:45 pmRNSDirector/PDMR Shareholding
18th Mar 20264:15 pmRNSDirector/PDMR Shareholding
18th Mar 202611:35 amRNSDirector/PDMR Shareholding
26th Feb 202611:30 amRNSDirector/PDMR Shareholding
25th Feb 20269:20 amRNSDirector/PDMR Shareholding
24th Feb 20264:55 pmRNSDirector/PDMR Shareholding
24th Feb 20264:50 pmRNSDirector/PDMR Shareholding
23rd Feb 20264:40 pmRNSDirector/PDMR Shareholding
23rd Feb 20264:35 pmRNSDirector/PDMR Shareholding
18th Feb 20264:50 pmRNSDirector/PDMR Shareholding
18th Feb 20264:45 pmRNSDirector/PDMR Shareholding
18th Feb 20264:00 pmRNSDirector/PDMR Shareholding
17th Feb 20263:35 pmRNSDirector/PDMR Shareholding
17th Feb 20263:30 pmRNSDirector/PDMR Shareholding
16th Feb 20262:40 pmRNSDirector/PDMR Shareholding
16th Feb 20262:35 pmRNSDirector/PDMR Shareholding
13th Feb 202610:30 amRNSDirector/PDMR Shareholding
12th Feb 20263:45 pmRNSDirector/PDMR Shareholding
12th Feb 20261:15 pmRNSDirector/PDMR Shareholding
10th Feb 20267:00 amRNSStrong execution and financial performance in 2025
2nd Feb 202610:00 amRNSTransfer of treasury shares & total voting rights
19th Jan 20264:00 pmRNSDirector/PDMR Shareholding
19th Jan 20262:20 pmRNSResult of Extraordinary General Meeting
13th Jan 202611:00 amRNSNotice of Results
5th Jan 202610:00 amRNSDirector/PDMR Shareholding
23rd Dec 20252:45 pmRNSDirector/PDMR Shareholding
23rd Dec 20252:45 pmRNSDirector/PDMR Shareholding
22nd Dec 20252:15 pmRNSDirector/PDMR Shareholding
22nd Dec 20252:15 pmRNSDirector/PDMR Shareholding
18th Dec 20255:00 pmRNSDirector/PDMR Shareholding
18th Dec 20255:00 pmRNSDirector/PDMR Shareholding
18th Dec 20253:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.